Literature DB >> 2817867

Antifungal susceptibility of 44 clinical isolates of Fusarium species determined by using a broth microdilution method.

A Reuben1, E Anaissie, P E Nelson, R Hashem, C Legrand, D H Ho, G P Bodey.   

Abstract

The MICs and minimum fungicidal concentrations of amphotericin B, natamycin, miconazole, itraconazole, and flucytosine against 17 isolates of Fusarium solani, 14 isolates of Fusarium moniliforme, 10 isolates of Fusarium oxysporum, and 3 isolates of Fusarium semitectum were determined by a broth microdilution method. Amphotericin B and natamycin were the most active agents tested and failed to show any inoculum size effect. In contrast, miconazole and itraconazole showed poor inhibitory and fungicidal activities, and the inoculum size had a major effect on the results. Flucytosine had no activity against any of the isolates tested.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2817867      PMCID: PMC172725          DOI: 10.1128/AAC.33.9.1647

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  13 in total

1.  Fusarium species osteomyelitis. Case report.

Authors:  R L Bourguignon; A F Walsh; J C Flynn; C Baro; E Spinos
Journal:  J Bone Joint Surg Am       Date:  1976-07       Impact factor: 5.284

2.  Fusarium solani infection during treatment for acute leukemia.

Authors:  C T Cho; T S Vats; J T Lowman; J W Brandsberg; F E Tosh
Journal:  J Pediatr       Date:  1973-12       Impact factor: 4.406

3.  In vitro antibiotic synergism against ocular fungal isolates.

Authors:  G A Stern
Journal:  Am J Ophthalmol       Date:  1978-09       Impact factor: 5.258

Review 4.  Disseminated fusarial infection in the immunocompromised host.

Authors:  S E Richardson; R M Bannatyne; R C Summerbell; J Milliken; R Gold; S S Weitzman
Journal:  Rev Infect Dis       Date:  1988 Nov-Dec

5.  The emerging role of Fusarium infections in patients with cancer.

Authors:  E Anaissie; H Kantarjian; J Ro; R Hopfer; K Rolston; V Fainstein; G Bodey
Journal:  Medicine (Baltimore)       Date:  1988-03       Impact factor: 1.889

6.  Fusarium oxysporum endophthalmitis.

Authors:  J J Rowsey; T E Acers; D L Smith; J A Mohr; D L Newsom; J Rodriguez
Journal:  Arch Ophthalmol       Date:  1979-01

7.  Fusarium brain abscess. Case report.

Authors:  G K Steinberg; R H Britt; D R Enzmann; J L Finlay; A M Arvin
Journal:  J Neurosurg       Date:  1983-04       Impact factor: 5.115

8.  Catheter-associated fungemia caused by Fusarium chlamydosporum in a patient with lymphocytic lymphoma.

Authors:  T E Kiehn; P E Nelson; E M Bernard; F F Edwards; B Koziner; D Armstrong
Journal:  J Clin Microbiol       Date:  1985-04       Impact factor: 5.948

9.  Disseminated Fusarium moniliforme infection after allogeneic marrow transplantation.

Authors:  C H June; P G Beatty; H M Shulman; M G Rinaldi
Journal:  South Med J       Date:  1986-04       Impact factor: 0.954

10.  Fusarium infection in burned patients.

Authors:  M S Wheeler; M R McGinnis; W A Schell; D H Walker
Journal:  Am J Clin Pathol       Date:  1981-03       Impact factor: 2.493

View more
  18 in total

1.  In vitro and in vivo experimental activities of antifungal agents against Fusarium solani.

Authors:  J Guarro; I Pujol; E Mayayo
Journal:  Antimicrob Agents Chemother       Date:  1999-05       Impact factor: 5.191

2.  Endophthalmitis caused by Fusarium proliferatum.

Authors:  Consuelo Ferrer; Jorge Alio; Alejandra Rodriguez; Mariano Andreu; Francisca Colom
Journal:  J Clin Microbiol       Date:  2005-10       Impact factor: 5.948

3.  Fungicidal activity of cecropin A.

Authors:  A J DeLucca; J M Bland; T J Jacks; C Grimm; T E Cleveland; T J Walsh
Journal:  Antimicrob Agents Chemother       Date:  1997-02       Impact factor: 5.191

4.  Analysis of growth characteristics of filamentous fungi in different nutrient media.

Authors:  J Meletiadis; J F Meis; J W Mouton; P E Verweij
Journal:  J Clin Microbiol       Date:  2001-02       Impact factor: 5.948

5.  Successful outcome of treatment of a disseminated infection due to Fusarium dimerum in a leukemia patient.

Authors:  Valérie Letscher-Bru; France Campos; Jocelyn Waller; Raoul Randriamahazaka; Ermanno Candolfi; Raoul Herbrecht
Journal:  J Clin Microbiol       Date:  2002-03       Impact factor: 5.948

Review 6.  Fusarium infection in lung transplant patients: report of 6 cases and review of the literature.

Authors:  Herman A Carneiro; Jeffrey J Coleman; Alejandro Restrepo; Eleftherios Mylonakis
Journal:  Medicine (Baltimore)       Date:  2011-01       Impact factor: 1.889

7.  Fusarium falciforme vertebral abscess and osteomyelitis: case report and molecular classification.

Authors:  Srilatha Edupuganti; Nadine Rouphael; Aneesh Mehta; Molly Eaton; John G Heller; Adam Bressler; Mary Brandt; Kerry O'Donnell
Journal:  J Clin Microbiol       Date:  2011-03-30       Impact factor: 5.948

8.  Effect of increasing inoculum sizes of pathogenic filamentous fungi on MICs of antifungal agents by broth microdilution method.

Authors:  A Gehrt; J Peter; P A Pizzo; T J Walsh
Journal:  J Clin Microbiol       Date:  1995-05       Impact factor: 5.948

9.  Invasive infection with Fusarium chlamydosporum in a patient with aplastic anemia.

Authors:  B H Segal; T J Walsh; J M Liu; J D Wilson; K J Kwon-Chung
Journal:  J Clin Microbiol       Date:  1998-06       Impact factor: 5.948

10.  Novel multilocus sequence typing scheme reveals high genetic diversity of human pathogenic members of the Fusarium incarnatum-F. equiseti and F. chlamydosporum species complexes within the United States.

Authors:  Kerry O'Donnell; Deanna A Sutton; Michael G Rinaldi; Cécile Gueidan; Pedro W Crous; David M Geiser
Journal:  J Clin Microbiol       Date:  2009-10-14       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.